Literature DB >> 4027152

Intracranial effects of nicardipine.

M R Gaab, T Czech, A Korn.   

Abstract

Preliminary investigations indicated that the calcium antagonist nicardipine improved cerebral vascular circulation and cerebral metabolism. Therefore we examined the effect of nicardipine on the cerebral vessels, cerebral oxygen tension, and intracranial pressure (ICP) in patients with cerebrovascular disturbances. In patients with previous minor stroke undergoing surgery for extra-intracranial anastomosis, we applied nicardipine topically to the operation site by means of a perfusor and measured the diameter of the cerebral vessels. After several minutes, the topically applied nicardipine produced marked dilatation in the small arterial cortical vessels and relaxation of vasospasm. In the two patients studied so far, we observed a rapid increase in the cerebral PO2, which remained elevated after the initial peak as long as the infusion continued. With a lower dose the increase in the intracranial pulse amplitude (PAICP) was antagonized by the considerable drop in blood pressure which occurred after 10 mg h-1 nicardipine. The results indicate that nicardipine dilates the cerebral vessels and increases the cerebral oxygen tension.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027152      PMCID: PMC1400795          DOI: 10.1111/j.1365-2125.1985.tb05145.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Experimental cerebral vasospasm in cats: modification by a new synthetic vasodilator YC-93.

Authors:  Y Handa; S Yoneda; T Koyama; M Matsuda; H Handa
Journal:  Surg Neurol       Date:  1975-04

2.  Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin.

Authors:  P M Epstein; K Fiss; R Hachisu; D M Andrenyak
Journal:  Biochem Biophys Res Commun       Date:  1982-04-14       Impact factor: 3.575

3.  Effect of Ca-antagonists on the contraction of cerebral and peripheral arteries produced by electrical and mechanical stimuli.

Authors:  K Nakayama; K Ishii; H Kato
Journal:  Gen Pharmacol       Date:  1983

Review 4.  ICP monitoring.

Authors:  M R Gaab; H E Heissler
Journal:  Crit Rev Biomed Eng       Date:  1984

Review 5.  Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.

Authors:  P H Stone; E M Antman; J E Muller; E Braunwald
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

6.  Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys and human patients.

Authors:  T Takenaka; J Handa
Journal:  Int J Clin Pharmacol Biopharm       Date:  1979-01

7.  Prevention of symptomatic vasospasm by topically applied nimodipine.

Authors:  L M Auer; Z Ito; A Suzuki; H Ohta
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

8.  Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats.

Authors:  K Aoki; Y Kawaguchi; K Sato; S Kondo; M Yamamoto
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

9.  Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

Authors:  G S Allen; H S Ahn; T J Preziosi; R Battye; S C Boone; S C Boone; S N Chou; D L Kelly; B K Weir; R A Crabbe; P J Lavik; S B Rosenbloom; F C Dorsey; C R Ingram; D E Mellits; L A Bertsch; D P Boisvert; M B Hundley; R K Johnson; J A Strom; C R Transou
Journal:  N Engl J Med       Date:  1983-03-17       Impact factor: 91.245

10.  Pathophysiology and treatment of coronary arterial spasm.

Authors:  H Yasue
Journal:  Chest       Date:  1980-07       Impact factor: 9.410

  10 in total
  4 in total

1.  Combined effects of hypocapnia and nicardipine on airway resistance: a pilot study.

Authors:  P Combes; B Fauvage
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

2.  Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage.

Authors:  M Shibuya; Y Suzuki; H Enomoto; T Okada; K Ogura; K Sugita
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 3.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

4.  Combined effects of nicardipine and hypocapnic alkalosis on cerebral vasomotor activity and intracranial pressure in man.

Authors:  P Combes; M Durand
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.